Trials give patients an opportunity to try new therapies or combinations of therapies. American Cancer Society: “Immunotherapy and Targeted Drugs for Eye Cancer,” “Immunotherapy for Melanoma ...

Hundreds of people in England with a rare form of cancer affecting the eye will soon be able to access ... when diagnosed at an advanced stage, with patients typically living for only a year ...

“Despite widespread malignant involvement, the patient was completely asymptomatic ... According to experts, even though eye ...

Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...

New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...

Baltimore — In one of Baltimore's poorest neighborhoods is one of its richest doctors. Dr. Michael Zollicoffer, known affectionately by his patients as Dr. Z., is a 66-year-old private family ...

Personalized cancer vaccines use a patient's own tumor proteins to trigger an immune response against cancer cells. While decades of research and advanced treatments have prolonged the lives of ...

Experts warn that these funding reductions could have severe consequences for cancer research and patient care. Some researchers fear that the cuts will lead to delayed discoveries, stalled ...

Burnett, with the Canadian Cancer Society says she's keeping a close eye on the latest research, too. Some of the issues that health-care workers try to help patients with include if and how a ...

enabling researchers and doctors worldwide to benefit and helping enhance patient care,” Benko added. There are approximately 1000 new eye cancer cases in the UK each year. The mortality rate of ...